Man Group PLC Maravai Lifesciences Holdings, Inc. Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $145,554 - $305,664	30,969 Added 158.01%	50,569 $331,000
Q3 2023 Nov 14, 2023	SELL	$9.14 - $12.85 $71,017 - $99,844	-7,770 Reduced 28.39%	19,600 $196,000
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $66,337 - $82,305	5,487 Added 25.07%	27,370 $340,000
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $284,260 - $360,631	21,883 New	21,883 $306,000
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $785,750 - $1.03 Million	-22,450 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $402,702 - $663,364	10,943 Added 95.1%	22,450 $1.1 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $45.0 $315,868 - $437,895	-9,731 Reduced 45.82%	11,507 $481,000
Q1 2021 May 17, 2021	BUY	$25.8 - $38.49 $547,940 - $817,450	21,238 New	21,238 $757,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $687M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.